Yoga for Functional Neurological Disorder (FND) – A Case Study
Objective: To describe key components of a yoga program for an individual with FND and evaluate feasibility and efficacy. Background: FND is the second most…Relationship between cardiovascular autonomic failure and cognitive performance in the α-synucleinopathies: preliminary cross-sectional analysis of the NHSS registry
Objective: To compare cognitive performances of patients with α-synucleinopathies with or without cardiovascular dysautonomia. Background: Cardiovascular dysautonomia is a disabling non-motor feature of the α-synucleinopathies and may…Comparison of different risk scores for Parkinson’s disease in a population-based 10-year study
Objective: To validate the “enhanced” PREDICT-PD algorithm in a longitudinal population-based cohort and compare its performance with other Parkinson's disease risk scores in identifying cases…Myoclonus in a Large Urban Center: 10 Year Experience
Objective: To describe various forms of myoclonus in admitted patients in a 10-year period. Background: Myoclonus consists of brief, shock-like involuntary movements. It may occur…Local Field Potential Recordings in Parkinson’s Disease at Home: A Case Series Report
Objective: To report novel, real-world use of chronic local field potential (LFP) sensing in patients with Parkinson’s disease (PD) outside-of-clinic settings. Background: Recent advancements in…Treatment of upper limb dystonic tremors: a retrospective study
Objective: Our study aimed to evaluate the clinical outcome of patients with upper-limb dystonic tremor (UL-DTs) treated at a tertiary hospital in London. Background: Tremor…Conservative iron chelation for Neuroferritinopathy
Objective: Evaluate the safety and efficacy of a conservative mode of iron chelation with deferiprone 30 mg/kg/day in neuroferritinopathy to limit iron-related neurodegeneration and associated…Neurodegeneration and neuroinflammation for biomarker development in MSA
Objective: To investigate the diagnostic and prognostic value of fluid-based and PET imaging biomarkers related to neurodegeneration and neuroinflammation in Multiple System Atrophy (MSA). Background:…ER Visits and Hospitalizations Among Patients Treated with Pimavanserin or Other-AAPs for Parkinson’s Disease Psychosis: Analysis of Medicare beneficiaries
Objective: To examine health resource utilization (HRU) outcomes among PDP patients treated with PIMA vs. other AAPs. Background: Real-world analysis demonstrating pimavanserin (PIMA) benefits, the…Variability of Plasma Levodopa Conveniently Reduced by More Frequent Administration of Smaller Doses of Carbidopa/Levodopa Using a Novel Functionally Scored Formulation
Objective: To evaluate the pharmacokinetics (PK) of 25/100 mg carbidopa (CD)/levodopa (LD) compared to half that amount given twice as often using a new, deeply…
- « Previous Page
- 1
- …
- 545
- 546
- 547
- 548
- 549
- …
- 1734
- Next Page »